Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
European Urology|July 6, 2014
Oncologic outcomes at 10 years following robotic radical prostatectomyMireya Diaz, James O Peabody, Victor Kapoor, et al.
The American Journal of Surgical Pathology|May 29, 2019
Papillary Renal Neoplasm With Reverse Polarity: A Morphologic, Immunohistochemical, and Molecular StudyKhaleel I Al-Obaidy, John N Eble, Liang Cheng, et al.
Urologic Oncology|April 9, 2020
The effect of multiplicity of PI-RADS 3 lesions on cancer detection rate of confirmatory targeted biopsy in patients diagnosed with prostate cancer and managed with active surveillanceGrace Yaguchi, Hoang J Tang, Mustafa Deebajah, et al.
The Canadian Journal of Urology|February 20, 2016
Predicting lymph node invasion in patients treated with robot-assisted radical prostatectomyFiras Abdollah, Dane E Klett, Jesse D Sammon, et al.
European Urology|December 7, 2021
Description of Surgical Technique and Oncologic and Functional Outcomes of the Precision Prostatectomy Procedure (IDEAL Stage 1-2b Study)Akshay Sood, Wooju Jeong, Isaac Palma-Zamora, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 20, 2019
Recurrent KRAS mutations in papillary renal neoplasm with reverse polarityKhaleel I Al-Obaidy, John N Eble, Mehdi Nassiri, et al.
Nature Communications|January 22, 2020
Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancerRitika Tiwari, Nishat Manzar, Vipul Bhatia, et al.
Oncotarget|February 24, 2015
Hydrazinobenzoylcurcumin inhibits androgen receptor activity and growth of castration-resistant prostate cancer in miceMin Wu, Sahn-Ho Kim, Indrani Datta, et al.
American Journal of Translational Research|February 21, 2012
Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatmentDejuan Kong, Elisabeth Heath, Wei Chen, et al.
BMC Medical Genomics|August 22, 2020
Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survivalYalei Chen, Sudha M Sadasivan, Ruicong She, et al.
Pageof 7